Newland Medical Associates

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

David J. Kuter, James B. Bussel, Roger M. Lyons et al. · The Lancet · 2008 · 862 citations

Medicine, Hematology, Pharmacology +6

Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts

Moshe Talpaz, Ronald Paquette, Lawrence B. Afrin et al. · Journal of Hematology & Oncology · 2013 · 94 citations · Full text

Medicine, Hematology, Pharmacology +14

Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics

Robert M. Rifkin, Rafat Abonour, Howard R. Terebelo et al. · Clinical Lymphoma Myeloma & Leukemia · 2014 · 34 citations

Medicine, Biomedical Informatics, Health Sciences +14

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG‐9500)

Stephen H. Petersdorf, Cathryn Rankin, David R. Head et al. · American Journal of Hematology · 2007 · 29 citations · Full text

Medicine, Oncology, Pharmacology +15

Efficacy, Hematologic Effects, and Dose of Ruxolitinib in Myelofibrosis Patients with Low Starting Platelet Counts (50–100 × 109/L): A Comparison to Patients with Normal or High Starting Platelet Counts

Moshe Talpaz, Ronald Paquette, Lawrence B. Afrin et al. · Blood · 2012 · 14 citations

Medicine, Hematology, Pharmacology +12